Lv5
968 积分 2024-01-06 加入
Lipoprotein(a) lowering and cardiovascular risk reduction by PCSK9 inhibitors
1个月前
已完结
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1个月前
已完结
Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
1个月前
已完结
Effects of resveratrol on postmenopausal women: a systematic review and meta-analysis
2个月前
已完结
Adverse effects of iodixanol: A retrospective safety study utilizing FAERS database signal analysis
2个月前
已完结
The real-world safety profile and potential mechanism of isatuximab: Integration of pharmacovigilance and transcriptomic analysis
2个月前
已完结
Analysis of infection-related adverse events induced by proton pump inhibitors based on the FAERS and JADER databases
2个月前
已完结
First in vivo base editing lowers cholesterol
2个月前
已完结
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models
2个月前
已完结
Therapeutic application of genome editing in dyslipidemia
2个月前
已关闭
皖公网安备34019202002308
